MitoQ as an antenatal antioxidant treatment improves markers of lung maturation in healthy and hypoxic pregnancy.

MLA

Lock, Mitchell C., et al. “MitoQ as an Antenatal Antioxidant Treatment Improves Markers of Lung Maturation in Healthy and Hypoxic Pregnancy.” Journal of Physiology, vol. 601, no. 16, Aug. 2023, pp. 3647–65. EBSCOhost, https://doi.org/10.1113/JP284786.

APA

Lock, M. C., Botting, K. J., Allison, B. J., Niu, Y., Ford, S. G., Murphy, M. P., Orgeig, S., Giussani, D. A., & Morrison, J. L. (2023). MitoQ as an antenatal antioxidant treatment improves markers of lung maturation in healthy and hypoxic pregnancy. Journal of Physiology, 601(16), 3647–3665. https://doi.org/10.1113/JP284786

Chicago

Lock, Mitchell C., Kimberley J. Botting, Beth J. Allison, Youguo Niu, Sage G. Ford, Michael P. Murphy, Sandra Orgeig, Dino A. Giussani, and Janna L. Morrison. 2023. “MitoQ as an Antenatal Antioxidant Treatment Improves Markers of Lung Maturation in Healthy and Hypoxic Pregnancy.” Journal of Physiology 601 (16): 3647–65. doi:10.1113/JP284786.